首页> 外国专利> Positive / negative cell selection and positive cell selection is mediated by peptide release

Positive / negative cell selection and positive cell selection is mediated by peptide release

机译:阳性/阴性细胞选择和阳性细胞选择由肽释放介导

摘要

(57) for discharging cells are positively selected by binding to a solid support or other beads via an antibody from a heterogeneous cell suspension [Abstract] The present invention relates to a method for non-enzymatic I provide. Involves the formation of a complex containing the cell suspension in solid supports coupled to the primary monoclonal antibody, which is, the method is bound to the cell surface antigens of the target cells are then. Were separated from the cell suspension and the complex then is contacted with a specific peptide which binds to the primary antibody was replaced with cell surface antigens and antibodies, the results, it is released from the complex to target cells. Further, the present invention provides a method for the positive / negative cell selection. Here, the target cell having a first antigen is selected from a heterogeneous cell suspension containing cells that are not desired with a second antigen. The present invention provides a method for identifying a specific peptide useful for releasing a target cell from the binding of specific monoclonal antibodies. The methods of the invention are particularly useful for the purification of lymphocytes or tumor cells is not desirable from a cell population positively selected and the accompanying positive selection of CD34 + hematopoietic stem cells. Then, CD34 + cells purified composition is useful for for reconstructing the immune system of the patient, the reinfusion of cancer patients after treatment of high capacity.
机译:(57)用于排出细胞的方法是通过抗体从异质细胞悬浮液中结合至固相支持物或其他珠子上。[摘要]本发明涉及一种非酶I方法。涉及形成包含在固体支持物中的细胞悬浮液的复合物,该固体支持物与第一单克隆抗体偶联,也就是说,该方法与靶细胞的细胞表面抗原结合。从细胞悬液中分离,然后使复合物与结合至一抗的特异性肽接触,然后用细胞表面抗原和抗体代替,结果,将其从复合物中释放至靶细胞。此外,本发明提供了用于阳性/阴性细胞选择的方法。在此,具有第一抗原的靶细胞选自异质细胞悬液,所述异质细胞悬液含有不需要第二抗原的细胞。本发明提供了用于鉴定可用于从特异性单克隆抗体的结合中释放靶细胞的特异性肽的方法。本发明的方法对于从阳性选择的细胞群和伴随的CD34 +造血干细胞的阳性选择的淋巴细胞或肿瘤细胞的纯化特别有用。然后,CD34 +细胞纯化的组合物可用于重建患者的免疫系统,高容量治疗后再注入癌症患者。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号